28,970 Shares in Addus HomeCare Corporation $ADUS Acquired by Campbell & CO Investment Adviser LLC

Key Points

• Campbell & CO Investment Adviser LLC acquired a new stake in Addus HomeCare Corporation, purchasing 28,970 shares valued at approximately $2.865 million during the first quarter.
• Insiders have sold a total of 28,616 shares of Addus HomeCare stock over the last three months, indicating significant insider trading activity.
• Addus HomeCare reported a 21.8% year-over-year revenue increase for its recent quarter, with earnings per share of $1.49, exceeding analysts' expectations.

Campbell & CO Investment Adviser LLC bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm bought 28,970 shares of the company's stock, valued at approximately $2,865,000. Campbell & CO Investment Adviser LLC owned approximately 0.16% of Addus HomeCare as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ADUS. Nuveen LLC acquired a new stake in shares of Addus HomeCare during the 1st quarter worth about $16,155,000. GAMMA Investing LLC increased its position in shares of Addus HomeCare by 10,307.8% during the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after purchasing an additional 129,672 shares in the last quarter. Bank of America Corp DE increased its position in shares of Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after purchasing an additional 128,211 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Addus HomeCare by 25.8% during the 1st quarter. Wellington Management Group LLP now owns 471,935 shares of the company's stock worth $46,670,000 after purchasing an additional 96,823 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its position in shares of Addus HomeCare by 1,229.4% during the 1st quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company's stock worth $9,978,000 after purchasing an additional 93,308 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Activity

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the transaction, the chief executive officer owned 166,461 shares of the company's stock, valued at $19,134,691.95. This trade represents a 13.06% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the transaction, the executive vice president directly owned 56,980 shares in the company, valued at $6,656,403.60. The trade was a 11.96% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. JMP Securities reiterated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. Barclays increased their price objective on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a report on Tuesday, August 19th. Royal Bank Of Canada increased their price objective on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a report on Friday, August 22nd. Macquarie reissued an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. Finally, Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Two research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $138.38.

Addus HomeCare Trading Down 0.0%

Shares of NASDAQ ADUS traded down $0.01 during mid-day trading on Friday, hitting $115.32. The company's stock had a trading volume of 15,102 shares, compared to its average volume of 189,059. The stock has a market cap of $2.12 billion, a price-to-earnings ratio of 25.46, a price-to-earnings-growth ratio of 1.76 and a beta of 0.80. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72. The company's fifty day simple moving average is $112.03 and its 200-day simple moving average is $107.00.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The company's revenue for the quarter was up 21.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.35 EPS. On average, sell-side analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.